Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease (Q35114490)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

Europe PubMed Central

Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Alzheimer's Disease Neuroimaging Initiative

0 references

Alzheimer's disease

0 references

0 references

3

object named as

Harald Hampel

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

John Q. Trojanowski

9

object named as

John Q Trojanowski

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

John Anthony Hardy

4

object named as

John Hardy

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

8

object named as

Eric Siemers

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Douglas R. Galasko

2

object named as

Douglas Galasko

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Richard A Frank

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Mony J de Leon

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Pankaj D Mehta

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Joseph Rogers

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

National Institute on Aging Biological Markers Working Group

10

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Neurobiology of Aging

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

521-536

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxidative damage to DNA: relation to species metabolic rate and life span

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammation and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Nitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet APP isoform ratios correlate with declining cognition in AD.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A carbon column-based liquid chromatography electrochemical approach to routine 8-hydroxy-2'-deoxyguanosine measurements in urine and other biologic matrices: a one-year evaluation of methods

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased oxidative damage to DNA in ALS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Association cortex, cerebellum, and serum concentrations of C1q and factor B in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of neuronal thread protein expression with neuritic sprouting: relevance to Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Human kallikrein 6 as a biomarker of alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential Level of Platelet Amyloid beta Precursor Protein Isoforms: An Early Marker for Alzheimer Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Abnormal pattern of platelet APP isoforms in Alzheimer disease and Down syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced levels of amyloid beta-peptide antibody in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular profile of reactive astrocytes--implications for their role in neurologic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

VH and VL gene usage by anti-beta-amyloid autoantibodies in Alzheimer's disease: detection of highly mutated V regions in both heavy and light chains

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum p97 levels as an aid to identifying Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased nuclear DNA oxidation in the brain in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical-neuropathological correlations in Alzheimer's disease and related dementias

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Human antibodies reactive with beta-amyloid protein in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased S100beta in the cerebrospinal fluid of patients with frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased soluble interleukin-6 receptor in cerebrospinal fluid of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholesterol, A beta and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis and quantitation of the beta-amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients with a monoclonal antibody-based immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of 3-nitrotyrosine and 5-nitro-gamma-tocopherol by high-performance liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Autoantibodies to amyloid-beta and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic accuracy of Alzheimer's disease: a clinicopathological study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum melanotransferrin, p97 as a biochemical marker of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Lewy Body Pathology in Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor rece

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased serum alpha 1-antichymotrypsin in patients with probable Alzheimer's disease: an acute phase reactant without the peripheral acute phase response

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha-1-antichymotrypsin and oxidative stress in the peripheral blood from patients with probable Alzheimer disease: a short-term longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of synaptic proteins in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The pentraxins: possible role in Alzheimer's disease and other innate inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of the classical complement pathway in brain tissue of Alzheimer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum autoantibodies against glial fibrillary acidic protein in brain aging and senile dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum anti-GFAP and anti-S100 autoantibodies in brain aging, Alzheimer's disease and vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Homocysteine, vitamin B6, and vascular disease in AD patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the DPC IMMULITE 2000 assay for total homocysteine in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Methodological considerations and factors affecting 8-hydroxy-2-deoxyguanosine analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical study of a urinary competitve ELISA for neural thread protein in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma homocysteine levels and mortality in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Soluble derivatives of the beta amyloid protein precursor in cerebrospinal fluid: alterations in normal aging and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha 1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebrospinal fluid concentrations of soluble amyloid beta-protein and apolipoprotein E in patients with Alzheimer's disease: correlations with amyloid load in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Alzheimer's disease and oxygen radicals: new insights

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

C-reactive protein and coronary heart disease: diagnostic and therapeutic implications for primary prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Complement activation by beta-amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

APOE genotype, plasma lipids, lipoproteins, and AD in community elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Neurofilament protein levels in CSF are increased in dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

beta-peptide immunization: a possible new treatment for Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Levels of total tau and tau protein phosphorylated at threonine 181 in patients with incipient and manifest Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Normal and abnormal biology of the beta-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Complement activation by neurofibrillary tangles in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Human brain S100 beta and S100 beta mRNA expression increases with age: pathogenic implications for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: the ApoEurope study. ApoEurope group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Neurofilament protein in cerebrospinal fluid: a marker of white matter changes.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Both total and phosphorylated tau are increased in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased levels of C1q in cerebrospinal fluid of living Alzheimer patients correlate with disease state

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation. Preliminary observations

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Amyloid beta protein in plasma from patients with sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Enzyme-linked immunosorbent assay for human autoantibody to glial fibrillary acidic protein: higher titer of the antibody is detected in serum of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Autoantibodies in neurodegenerative diseases: antigen-specific frequencies and intrathecal analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Glutamine synthetase in cerebrospinal fluid, serum, and brain: a diagnostic marker for Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased incidence of anti-beta-amyloid autoantibodies secreted by Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Deficiency of complement defense protein CD59 may contribute to neurodegeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2803%2900002-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0197-4580(03)00002-2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35114490&oldid=1975379049"